I. D. van Kessel

Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro

N. Datson, B. Wieringa, A. González-Barriga, 2017, Nucleic acid therapeutics.

Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat

Eric T. Wang, E. Wang, S. V. van Heeringen, 2017, RNA biology.

Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy

B. Wieringa, A. González-Barriga, J. Kranzen, 2014, Neuromuscular Disorders.

Design and Analysis of Effects of Triplet Repeat Oligonucleotides in Cell Models for Myotonic Dystrophy

J. Fransen, B. Wieringa, A. González-Barriga, 2013, Molecular therapy. Nucleic acids.

Trinucleotide-repeat expanded and normal DMPK transcripts contain unusually long poly(A) tails despite differential nuclear residence.

B. Wieringa, I. D. van Kessel, D. G. Wansink, 2017, Biochimica et biophysica acta. Gene regulatory mechanisms.

CRISPR/Cas9-Induced (CTG⋅CAG)n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing

M. Willemse, B. Wieringa, V. Mouly, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.